269P Prostate cancer harboring low COMT expression correlates with a poor prognosis and response to enzalutamide

Autor: Maekawa, S., Takata, R., Ikarashi, D., Matsuura, T., Kato, R., Kanehira, M., Sugimura, J., Obara, W.
Zdroj: In Annals of Oncology November 2023 34 Supplement 4:S1578-S1578
Databáze: ScienceDirect